Tag: MEK inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to MEK inhibitor

SunTrust Robinson Has Just Reaffirmed $16.0 Target Price Per Share on Array Biopharma ...

Added to Collection on: 2018-01-24 00:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Time to Reconsider Array BioPharma Inc. (ARRY) After Achieving 52-Week High?

Added to Collection on: 2018-03-07 23:11:15

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
IDEAYA (IDYA) Braces For Busy Year - MUM's The Word, Stock Up Over 20%

Added to Collection on: 2020-01-02 12:30:00

Tags for this article:

Eye color
Melanoma
Uveal melanoma
MEK inhibitor
Medicine
Clinical medicine
Health
Chloroarenes
J. William Harbour
DecisionDx-UM
Novartis

Click the tags to see associated articles and topics

View Article Details
Boosting stem cell activity can enhance immunotherapy benefits

Added to Collection on: 2020-11-23 18:56:15

Tags for this article:

Branches of biology
Biology
Life Sciences
Stem cells
Biotechnology
Cell biology
Immunology
Immunotherapy
Cancer immunotherapy
Oncology
MEK inhibitor
T cell

Click the tags to see associated articles and topics

View Article Details
[2021] BRAF Kinase Inhibitors Market – Global Exclusive Analysis by Leading Players Overview by ...

Added to Collection on: 2021-04-14 15:00:00

Tags for this article:

Clinical medicine
Chemical compounds
Medicine
Orphan drugs
Cancer treatments
Chemotherapy
Sulfonamides
Benzamides
MEK inhibitor
Vemurafenib
Cobimetinib
Dabrafenib

Click the tags to see associated articles and topics

View Article Details
IDEAYA Reports Darovasertib (IDE196) Monotherapy Overall Survival Data and Observes Early ...

Added to Collection on: 2021-04-16 09:56:15

Tags for this article:

Medicine
Clinical medicine
Health sciences
Orphan drugs
Cancer treatments
Organobromides
Cancer research
MEK inhibitor
Antineoplastic drugs
Melanoma
Binimetinib
Immunocore
Richard Carvajal
Nashville
IDEAYA Biosciences Inc.
Skin Melanoma

Click the tags to see associated articles and topics

View Article Details
Day One Biopharmaceuticals Begins Pivotal Pan-RAF Inhibitor Trial in Pediatric Brain Cancer ...

Added to Collection on: 2021-05-11 15:00:00

Tags for this article:

Cancer
Clinical medicine
Brain tumor
Medicine
Glioma
MEK inhibitor
Neuro-oncology
BRAF
Sulfonamides
Brainstem glioma
Day One

Click the tags to see associated articles and topics

View Article Details
Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)

Added to Collection on: 2023-12-15 19:09:32

Tags for this article:

Bristol-Myers Squibb
Antineoplastic drugs
Immune system
Breakthrough therapy
Orphan drugs
Nivolumab
Relatlimab
Checkpoint inhibitor
Programmed cell death protein 1
Melanoma
Immunotherapy
MEK inhibitor

Click the tags to see associated articles and topics

View Article Details
Dr Li on the Use of ADG126 With Pembrolizumab in MSS CRC - OncLive

Added to Collection on: 2024-01-21 00:27:55

Tags for this article:

Orphan drugs
Antineoplastic drugs
BRAF
Oncogenes
Pembrolizumab
V600E
Colorectal cancer
MEK inhibitor
Targeted therapy

Click the tags to see associated articles and topics

View Article Details
Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

Added to Collection on: 2025-04-28 02:42:08

Tags for this article:

Antineoplastic drugs
Orphan drugs
Lung cancer
KRAS
Oncogenes
MEK inhibitor
Targeted therapy
Non-small-cell lung cancer
Toni Choueiri
American Association for Cancer Research
Pembrolizumab
Sotorasib
Dana–Farber Cancer Institute

Click the tags to see associated articles and topics

View Article Details
Book a Demo